Actively Recruiting
Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes
Led by University Hospital, Lille · Updated on 2025-12-23
600
Participants Needed
1
Research Sites
257 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies. Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies
CONDITIONS
Official Title
Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults
- Persons able to understand and object to the information provided.
- Type 2 diabetic patient free of heart failure 63;stade B
- Patient affiliated with a social security scheme.
- Patient agreeing to sign the informed consent form
You will not qualify if you...
- Patient with dementia
- Patient with at least one of the criteria for heart failure 63;stade B
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Roger Salengro, CHU Lille
Lille, France, 59037
Actively Recruiting
Research Team
C
Charlotte Cordonnier, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here